Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune hemolytic anemia.

J V Dacie

    Archives of Internal Medicine
    |October 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Autoimmune hemolytic anemia (AIHA) involves autoantibodies targeting red blood cells (RBCs). These antibodies, classified by temperature (warm/cold), determine destruction sites and mechanisms, involving complement or spleen interactions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Refractory anaemia (Fanconi type): Its Incidence in Three Members of One Family, with in One Case a Relationship to Chronic Haemolytic Anaemia with Nocturnal Haemo-Globinuria (Marchiafava-Micheli Disease or `Nocturnal Haemoglobinuria').

    Archives of disease in childhood·2010
    Same author

    Blood-loss in battle casualties; use of transfusion fluids.

    Lancet (London, England)·2010
    Same author

    Blood Transfusion in Nocturnal Haemoglobinuria.

    British medical journal·2010
    Same author

    Natural history of paroxysmal nocturnal hemoglobinuria.

    The New England journal of medicine·1995
    Same author

    Partial ankyrin and spectrin deficiency in severe, atypical hereditary spherocytosis.

    The New England journal of medicine·1988
    Same author

    Red cell fragmentation in human disease (a light and scanning electron microscope study).

    Blood cells·1984

    Area of Science:

    • Immunology
    • Hematology
    • Autoimmunity

    Background:

    • Autoimmune hemolytic anemia (AIHA) is characterized by autoantibodies against red blood cells (RBCs).
    • Antibody types (IgG, IgM, IgA) and specificity (Rh, I, P) vary.
    • Antibody behavior (complement fixation) influences RBC destruction pathways.

    Purpose of the Study:

    • To elucidate the characteristics of warm-type and cold-type autoantibodies in AIHA.
    • To describe the mechanisms of RBC destruction mediated by different autoantibody types.
    • To identify potential factors contributing to the breakdown of immunological tolerance in AIHA.

    Main Methods:

    • Classification of autoantibodies based on thermal type (warm/cold) and immunoglobulin class (IgG, IgM, IgA).
    • Analysis of antibody specificity (e.g., Rh, I, P).

    Related Experiment Videos

  • Evaluation of complement (C) fixation and its role in RBC destruction.
  • Assessment of RBC destruction sites (spleen, liver) and mechanisms (intravascular lysis, phagocytosis).

    • Main Results:

    • Warm-type autoantibodies are typically Rh-specific IgG and do not fix complement, causing splenic RBC destruction.
    • Cold-type antibodies include IgM (often anti-I) and Donath-Landsteiner (DL) IgG (anti-P) antibodies.
    • IgM and DL antibodies can fix complement, leading to intravascular lysis or hepatic/splenic phagocytosis of C3-coated RBCs.

    Conclusions:

    • AIHA autoantibody characteristics dictate the pathogenesis and clinical presentation.
    • Complement fixation is a key differentiator in RBC destruction mechanisms.
    • Genetic factors, infections, drugs, and immune dysregulation likely contribute to AIHA development.